BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9247783)

  • 1. Nephrotic syndrome associated with alpha interferon therapy in chronic myeloid leukemia.
    Budak-Alpdoğan T; Lawrence RA; Bayik M; Akoğlu E
    Clin Nephrol; 1997 Jul; 48(1):59-60. PubMed ID: 9247783
    [No Abstract]   [Full Text] [Related]  

  • 2. Thrombotic microangiopathy associated with alpha-interferon therapy for chronic myeloid leukaemia.
    Galesic K; Bozic B; Racic I; Scukanec-Spoljar M
    Nephrology (Carlton); 2006 Feb; 11(1):49-52. PubMed ID: 16509932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of chronic myeloid leukemia with interferon-alpha].
    Szomor A; Molnár L; Nagy A; Dávid M; Alizadeh H; Kecskés M; Vidra T; Kereskai L; Pajor L; Losonczy H
    Orv Hetil; 2000 Nov; 141(48):2601-4. PubMed ID: 11141958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current controversies on the role of interferon-alpha for therapy of chronic myeloid leukemia.
    Heimpel H; Allan NC; Baccarani M; Guilhot F; Hehlmann R; Horowitz M; Kluin-Nelemans J; Schaefer U; Storb R; Thaler J
    Bone Marrow Transplant; 1996 May; 17 Suppl 3():S39. PubMed ID: 8769699
    [No Abstract]   [Full Text] [Related]  

  • 5. Interferon-alpha-induced focal segmental glomerulosclerosis in chronic myelogenous leukemia: a case report and review of the literature.
    Bremer CT; Lastrapes A; Alper AB; Mudad R
    Am J Clin Oncol; 2003 Jun; 26(3):262-4. PubMed ID: 12796597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interferon-alpha in the treatment of chronic myeloid leukemia].
    Guilhot F
    Rev Prat; 1999 Mar; 49(5):464-6. PubMed ID: 10358394
    [No Abstract]   [Full Text] [Related]  

  • 7. [Interferon-alpha therapy in chronic myelogenous leukemia].
    Ohnishi K
    Rinsho Ketsueki; 2000 Apr; 41(4):275-9. PubMed ID: 10846454
    [No Abstract]   [Full Text] [Related]  

  • 8. Rapidly progressive renal graft failure associated with interferon-alpha treatment in a patient with chronic myelogenous leukemia.
    Bren A; Kandus A; Ferluga D
    Clin Nephrol; 1998 Oct; 50(4):266-7. PubMed ID: 9799075
    [No Abstract]   [Full Text] [Related]  

  • 9. [Preliminary results of interferon alpha treatment for patients with chronic myelogenous leukemia].
    Popławska-Szczygłowska L; Starzyńska J; Chmarzyńska-Mróz E
    Pol Tyg Lek; 1996 May; 51(19-22):283-4. PubMed ID: 9289711
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapy of chronic myeloid leukemia].
    Freund M
    Internist (Berl); 1993 Jun; 34(6):542-9. PubMed ID: 8335444
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hemolitic uremic syndrome with hypertransaminasemia following treatment by interferon for chronic myeloid leukemia].
    Denizon N; Beraud JJ; Mourad G; Blanc P; Bureau JP; Navarro M; Lavabre-Bertrand T
    Gastroenterol Clin Biol; 2001 Nov; 25(11):1039-40. PubMed ID: 11845064
    [No Abstract]   [Full Text] [Related]  

  • 12. [Occurrence of autoimmune complications in patients with chronic myelocytic leukemia during treatment with interferon alfa].
    Tóthová E; Stecová N; Kafková A; Fricová M; Svorcová E
    Vnitr Lek; 2002 May; 48(5):380-3. PubMed ID: 12061203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of interferon-alpha in chronic myeloid leukemia.
    Kumar L; Basade M; Gulati SC
    J Assoc Physicians India; 1995; Suppl 3():26-32. PubMed ID: 8773119
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effectiveness of treatment with native alpha-interferon (Wellferon) in patients with chronic myeloid leukemia].
    Rukavitsyn OA
    Vopr Onkol; 1997; 43(6):606-9. PubMed ID: 9479361
    [No Abstract]   [Full Text] [Related]  

  • 15. [Mobilization of Ph-negative hematopoietic stem cells using rhG-CSF in patients with chronic myeloid leukemia treated with interferon-alfa. Experience of the Clinic Hospital of Barcelona].
    Carreras E
    Sangre (Barc); 1997 Apr; 42 Suppl 1():24-6. PubMed ID: 9381296
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chronic myeloid leukemia: current pathogenetic aspects and new therapeutic approaches (a foreign literature review)].
    Petukhov VI; Strozha IL; Bondare DK
    Ter Arkh; 2001; 73(12):96-101. PubMed ID: 11858124
    [No Abstract]   [Full Text] [Related]  

  • 17. [The effectiveness of interferon-alpha therapy in Ph-positive chronic myeloid leukemia].
    Bogdanov KV; Frolova OI; Marinets OV; Ogorodnikova IuS; Afanas'ev BV; Zaritskiĭ AIu
    Vopr Onkol; 2003; 49(2):189-92. PubMed ID: 12785203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment with interferon alpha of the lymphoblastic transformation of chronic myeloid leukemia].
    Canales MA; Martínez J; Quevedo E; Hernández-Navarro F
    Sangre (Barc); 1999 Dec; 44(6):493-4. PubMed ID: 10822770
    [No Abstract]   [Full Text] [Related]  

  • 19. [Changing concept of conventional therapy in chronic myelogenous leukemia].
    Ueda R
    Rinsho Ketsueki; 2000 Apr; 41(4):268-71. PubMed ID: 10846452
    [No Abstract]   [Full Text] [Related]  

  • 20. [Stem cell transplantation for chronic myelogenous leukemia].
    Takayama N; Okamoto S
    Rinsho Ketsueki; 2000 Apr; 41(4):283-7. PubMed ID: 10846456
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.